Details of the Drug Formulations

General Information of Drug (ID: DM8HO1L)

Drug Name
Pyridostigmine Drug Info
Synonyms
Pyridostigminum; Pyridostigmine Bromine; Mestinon (TN); Mestinon-SR; Regonol (TN); AQ-776/42801589; Pyridinium, 3-hydroxy-1-methyl-, dimethylcarbamate (ester); Pyridinium, 3-(((dimethylamino)carbonyl)oxy)-1-methyl-(9CI); (1-methylpyridin-1-ium-3-yl) N,N-dimethylcarbamate; 1-methyl-3-pyridiniumyl dimethylcarbamate; 3-(((Dimethylamino)carbonyl)oxy)-1-methylpyridinium
Indication
Disease Entry ICD 11 Status REF
Myasthenia gravis 8C6Y Approved [1]
Coronavirus Disease 2019 (COVID-19) 1D6Y Phase 2/3 [2]
Therapeutic Class
Parasympathomimetics
Cross-matching ID
PubChem CID
4991
ChEBI ID
CHEBI:8665
CAS Number
155-97-5
TTD ID
D0O2WB
ACDINA ID
D00571

Full List of Drug Formulations Containing This Drug

Pyridostigmine 60 mg tablet
Company Formulation ID FDA Description
American Health Packaging; Impax Generics; RemedyRepack F18300 Stearic acid; Anhydrous lactose; Magnesium stearate; Silicon dioxide
Bryant Ranch Prepack F18296 Stearic acid; Anhydrous lactose; Silicon dioxide; Hydroxypropyl cellulose, low substituted
Major Pharmaceuticals F18297 Stearic acid; Anhydrous lactose; Silicon dioxide; Low-substituted hydroxypropyl cellulose, unspecified
RemedyRepack F18298 Stearic acid; Anhydrous lactose; Magnesium stearate; Colloidal silicon dioxide
Oceanside Pharmaceuticals; Valeant Pharmaceuticals F18299 Stearic acid; Lactose, unspecified form; Silicon dioxide
CorePharma F18301 Stearic acid; Anhydrous lactose; Silicon dioxide
Cadila Healthcare; Zydus Pharmaceuticals F18295 Stearic acid; Anhydrous lactose; Colloidal silicon dioxide; Hydroxypropyl cellulose, low substituted
------------------------------------------------------------------------------------
⏷ Show the Full List of 7 Formulation(s)
Pyridostigmine 180 mg tablet
Company Formulation ID FDA Description
Impax Generics F18291 Lactose, unspecified form; Magnesium stearate; Silicon dioxide; Carnauba wax; Copovidone k25-31
Alvogen F18292 Magnesium stearate; Calcium phosphate, unspecified form; Silicon dioxide; Carnauba wax; Zein
Oceanside Pharmaceuticals F18293 Magnesium stearate; Silicon dioxide; Carnauba wax; Tribasic calcium phosphate; Zein
Valeant Pharmaceuticals F18294 Magnesium stearate; Silicon dioxide; Carnauba wax; Tribasic calcium phosphate
------------------------------------------------------------------------------------

References

1 FDA Approved Drug Products from FDA Official Website. 2009. Application Number: (ANDA) 040457.
2 ClinicalTrials.gov (NCT04343963) Pyridostigmine in Severe SARS-CoV-2 Infection. U.S. National Institutes of Health.